by Maggie Ruper
WHAS11.com
Posted on March 7, 2012 at 11:50 PM
Updated today at 12:01 AM
LOUISVILLE, Ky. (WHAS11) -- New research published Wed. in the journal Science Translation Medicine, shows organ transplant recipients may not require anti-rejection medication after surgery.
The study, authored by University of Louisville professor Suzanne Ildstad, M.D., suggests bone marrow stem cells are able to trick the recipients immune system into thinking the donated organ is part of the patients natural self. It therefore eliminates the need for patients to take dozens of daily anti-rejection drugs.
Normally, if I have to transplant a kidney into a patient they have to take immunosuppression drugs for their lifetime and that's about 15 to 25 pills a day, said Ildstad.
Louisville native and father of four, Rob Waddell underwent the procedure in 2009 at Northwestern Memorial Hospital. He suffered from Polycystic Kidney Disease since he was 11 years old. His new kidney and the stem cells were donated to him by his next door neighbor.
It was a match and the rest is history. He's what I call my guardian angel," said Wadell.
The results were considered important because the technique worked for patients who did not have well-matched or related donors.
Read more:
UofL Professor’s study: Stem cells eliminate need for anti-rejection drugs